CT
Cytek Biosciences, Inc.
CTKB · NASDAQ
$5.68 -0.87% (-$0.05)
1M +24.02%
Market Cap $733.5M
P/E Ratio -
Div. Yield -
ROE 23.53%
Bulios Fair Price
$4.85
14.6% downside
Trenutna cena
$5.68
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CTKB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
66 /100
Fair P/S 3.55x
P/B 2.28x
P/E N/A
Growth
43 /100
Stable Rev. growth 7.10%
Book val. growth 7.03%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 53.23%
Net margin 38.98%
Op. margin 21.60%
Quality
6 /100
Poor ROIC 23.49%
ROE 23.53%
ROA 18.03%
Debt
69 /100
Low Debt/Equity 0.08x
Current ratio 4.48x
Int. coverage -22.16x
Stability
45 /100
Moderate Beta 1.19x
Rev. volatility 9.09%
EPS volatility 541.00%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CTKB
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Wenbin Jiang
Employees
682
Headquarters
Fremont
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report